1. Home
  2. UG vs IGC Comparison

UG vs IGC Comparison

Compare UG & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United-Guardian Inc.

UG

United-Guardian Inc.

HOLD

Current Price

$7.33

Market Cap

36.5M

ML Signal

HOLD

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

HOLD

Current Price

$0.31

Market Cap

32.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UG
IGC
Founded
1942
2005
Country
United States
United States
Employees
N/A
70
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.5M
32.0M
IPO Year
1995
2005

Fundamental Metrics

Financial Performance
Metric
UG
IGC
Price
$7.33
$0.31
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.25
AVG Volume (30 Days)
6.6K
924.7K
Earning Date
05-11-2026
03-19-2026
Dividend Yield
7.10%
N/A
EPS Growth
N/A
59.09
EPS
0.20
N/A
Revenue
$10,545,468.00
$1,271,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$13.06
P/E Ratio
$36.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.58
$0.24
52 Week High
$8.78
$0.46

Technical Indicators

Market Signals
Indicator
UG
IGC
Relative Strength Index (RSI) 51.75 67.37
Support Level $6.92 $0.31
Resistance Level $7.42 $0.36
Average True Range (ATR) 0.24 0.01
MACD 0.01 0.01
Stochastic Oscillator 37.42 80.56

Price Performance

Historical Comparison
UG
IGC

About UG United-Guardian Inc.

United-Guardian Inc manufactures, markets and develops specialty cosmetic, personal care and sexual wellness ingredients, and a line of healthcare products including pharmaceuticals and medical lubricants. Its pharmaceutical products are distributed through national drug wholesalers to pharmacies, physicians, and hospitals. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. The company's majority of revenue is derived from the sales of Pharmaceuticals in the United States.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Share on Social Networks: